"Global Yellow Fever Vaccine Market Overview:
Global Yellow Fever Vaccine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Yellow Fever Vaccine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Yellow Fever Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Yellow Fever Vaccine Market:
The Yellow Fever Vaccine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Yellow Fever Vaccine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Yellow Fever Vaccine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Yellow Fever Vaccine market has been segmented into:
Hospitals
Point Of Care Centers
By Application, Yellow Fever Vaccine market has been segmented into:
Pain Management Drugs
Oral Rehydration
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Yellow Fever Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Yellow Fever Vaccine market.
Top Key Players Covered in Yellow Fever Vaccine market are:
Takeda Pharmaceutical Company Ltd
Merck & Co Inc
GlaxoSmithKline PLC
Biological E Limited
Panacea Biotec
iBio Inc
FSUE Chumakov.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Yellow Fever Vaccine Market by Type
4.1 Yellow Fever Vaccine Market Snapshot and Growth Engine
4.2 Yellow Fever Vaccine Market Overview
4.3 Hospitals
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Hospitals: Geographic Segmentation Analysis
4.4 Point Of Care Centers
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Point Of Care Centers: Geographic Segmentation Analysis
Chapter 5: Yellow Fever Vaccine Market by Application
5.1 Yellow Fever Vaccine Market Snapshot and Growth Engine
5.2 Yellow Fever Vaccine Market Overview
5.3 Pain Management Drugs
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pain Management Drugs: Geographic Segmentation Analysis
5.4 Oral Rehydration
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Oral Rehydration: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Yellow Fever Vaccine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 TAKEDA PHARMACEUTICAL COMPANY LTD
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MERCK & CO INC
6.4 GLAXOSMITHKLINE PLC
6.5 BIOLOGICAL E LIMITED
6.6 PANACEA BIOTEC
6.7 IBIO INC
6.8 FSUE CHUMAKOV.
Chapter 7: Global Yellow Fever Vaccine Market By Region
7.1 Overview
7.2. North America Yellow Fever Vaccine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Hospitals
7.2.4.2 Point Of Care Centers
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Pain Management Drugs
7.2.5.2 Oral Rehydration
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Yellow Fever Vaccine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Hospitals
7.3.4.2 Point Of Care Centers
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Pain Management Drugs
7.3.5.2 Oral Rehydration
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Yellow Fever Vaccine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Hospitals
7.4.4.2 Point Of Care Centers
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Pain Management Drugs
7.4.5.2 Oral Rehydration
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Yellow Fever Vaccine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Hospitals
7.5.4.2 Point Of Care Centers
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Pain Management Drugs
7.5.5.2 Oral Rehydration
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Yellow Fever Vaccine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Hospitals
7.6.4.2 Point Of Care Centers
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Pain Management Drugs
7.6.5.2 Oral Rehydration
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Yellow Fever Vaccine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Hospitals
7.7.4.2 Point Of Care Centers
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Pain Management Drugs
7.7.5.2 Oral Rehydration
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Yellow Fever Vaccine Scope:
|
Report Data
|
Yellow Fever Vaccine Market
|
|
Yellow Fever Vaccine Market Size in 2025
|
USD XX million
|
|
Yellow Fever Vaccine CAGR 2025 - 2032
|
XX%
|
|
Yellow Fever Vaccine Base Year
|
2024
|
|
Yellow Fever Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Takeda Pharmaceutical Company Ltd, Merck & Co Inc, GlaxoSmithKline PLC, Biological E Limited, Panacea Biotec, iBio Inc, FSUE Chumakov..
|
|
Key Segments
|
By Type
Hospitals
Point Of Care Centers
By Applications
Pain Management Drugs
Oral Rehydration
|
